STAT

Fecal transplants move into the mainstream to treat difficult infection

For the first time, an influential medical group is recommending fecal transplants for certain C. diff infections.
Source: CDC

Fecal transplants are increasingly becoming a mainstream treatment.

For the first time, an influential medical group is recommending the procedure — in which donor fecal matter is transferred to a patient — for individuals who have repeatedly failed standard treatments for severe diarrhea caused by Clostridium difficile, commonly known as C. diff.

The Infectious Diseases Society of America issued the new guidelines Thursday for combatting the bacterial infection, which sickens nearly half a million Americans every year.

“We are now including the recommendation  …  that they be at least considered for fecal microbiome transplantation,” said Dr. Clifford McDonald, one

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks